Secnidazole Patent Expiration

Secnidazole is Used for treating bacterial vaginosis and trichomoniasis in women and female patients 12 years of age and older. It was first introduced by Lupin Inc in its drug Solosec on Sep 15, 2017.


Secnidazole Patents

Given below is the list of patents protecting Secnidazole, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Solosec US10335390 Secnidazole for use in the treatment of bacterial vaginosis Sep 04, 2035 Lupin
Solosec US10682338 Secnidazole for use in the treatment of bacterial vaginosis Sep 04, 2035 Lupin
Solosec US10849884 Secnidazole for use in the treatment of bacterial vaginosis Sep 04, 2035 Lupin
Solosec US10857133 Secnidazole for use in the treatment of bacterial vaginosis Sep 04, 2035 Lupin
Solosec US11000507 Secnidazole for use in the treatment of bacterial vaginosis Sep 04, 2035 Lupin
Solosec US11000508 Secnidazole for use in the treatment of trichomoniasis Sep 04, 2035 Lupin
Solosec US11020377 Secnidazole for use in the treatment of bacterial vaginosis Sep 04, 2035 Lupin
Solosec US11324721 Secnidazole for use in the treatment of trichomoniasis Sep 04, 2035 Lupin
Solosec US11602522 Secnidazole for use in the treatment of sexually transmitted infection Sep 04, 2035 Lupin
Solosec US11684607 Secnidazole for use in the treatment of bacterial vaginosis Sep 16, 2035 Lupin


A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Secnidazole's patents.

Given below is the list recent legal activities going on the following patents of Secnidazole.

Event Date Patent/Publication
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 17 Jul, 2024 US11000507
Payment of Maintenance Fee, 4th Year, Large Entity 17 Jul, 2024 US11000508
Payment of Maintenance Fee, 4th Year, Large Entity 11 Dec, 2023 US10849884
Payment of Maintenance Fee, 4th Year, Large Entity 11 Dec, 2023 US10857133
Payment of Maintenance Fee, 4th Year, Large Entity 28 Jun, 2023 US10682338
Electronic Review 27 Jun, 2023 US11684607
Email Notification 27 Jun, 2023 US11684607
Mail Patent eGrant Notification 27 Jun, 2023 US11684607
Patent eGrant Notification 27 Jun, 2023 US11684607
Patent Issue Date Used in PTA Calculation 27 Jun, 2023 US11684607



Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳